← FDA Drug Approvals (Drugs@FDA)
NEVIRAPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2016-11-23
Drug application
- FDA Application #
ANDA208616- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NEVIRAPINE
- Generic name
- Nevirapine
- Active ingredients
- NEVIRAPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA
- First approval
- 2016-11-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown